Policy / Regulatory

Biden’s Executive Order Boosts US Bio-Economy, Targets China’s Biotech Rise

CompanyDeals

QuantuMDx and Sansure Biotech Partner to Commercialize Q-POC in China

CompanyDrug

InnoCare Pharma’s BCL2 Inhibitor ICP-248 Gains NMPA Approval for Clinical Study

CompanyDrug

BeiGene’s Tislelizumab Meets Primary Endpoint in HCC Study at ESMO

CompanyDrug

Luye Pharma’s BA-CovMab Receives NMPA Approval for COVID-19 Clinical Trials

Policy / Regulatory

Jiangsu Healthcare to Cover All Psychological Treatments Under BMI

CompanyDeals

Leadinno Medical Valley Raises RMB 100M in Series A Financing for Neuromodulation Devices

CompanyDrug

Transcenta’s TST001 Shows Promise in Gastric Cancer Trial with 73.3% Response Rate

CompanyDrug

CSPC Pharmaceutical’s TG103 Gains NMPA Approval for NASH and Alzheimer’s Trials

CompanyDrug

Jingxin Pharmaceutical Receives NMPA Approval for JBPOS0101 and JX7002 Trials

Drug

China’s Retail Pharmacy O2O Sales Surge to USD 2.9B in 2021

Medical DevicePolicy / Regulatory

National High-Value Medical Consumables VBP Round Targets Orthopedic Spine Products